Portuguese 
Spanish 
Empty medicine blister packs hide aluminum, technical plastic, and disposal challenges that start at home but are already entering a Brazilian reuse route linked to the pharmaceutical industry, selective collection, and the circular economy.
Usually thrown in the regular trash after the end of a treatment, empty medicine blister packs have become part of a Brazilian initiative aimed at decontamination, proper disposal, and reuse of materials used in pharmaceutical packaging.
Little remembered in recycling discussions, this waste draws attention because it is present in millions of homes and combines, in a small piece, industrial value components that often disappear along with household waste.
Conducted by Eurofarma within the +Verde program, the action includes products with environmental measures related to packaging and post-consumption, bringing the disposal of medicines closer to a more organized reuse logic.
-
Flexible PEX Plumbing Revolutionizes Bathrooms and Kitchens, Reducing Hidden Connections and Speeding Up Installations
-
Brazil Unveils Search and Rescue Drone Capable of Carrying 50 kg, Equipped with Thermal Camera and Lifebuoy Deployment for River, Flood, Beach, and Remote Area Assistance
-
Labor Shortage: The Essential Profession Keeping Brazil’s Buildings, Hospitals, and Businesses Running Faces Workforce Deficit with Over 802,000 Employed
-
Adventurer Camps in Giant Fig Tree in the Brazilian Amazon After Spotting It with Drone
According to public information from the company, the pharmaceutical company developed a methodology approved by Anvisa for the domestic decontamination of primary packaging of certain medicines, allowing blister packs in direct contact with the product to become inert and proceed to selective collection.
Recycling of medicine blister packs in Brazil
At the center of this process are the blisters, the technical name for the packs used to store tablets and capsules, which seem simple at first glance but combine different materials to preserve the quality of the medicines.
These packages usually combine aluminum, PVC, and PVDC, materials used to protect the medicine against moisture, light, and oxygen, creating an efficient barrier during consumption but more complex when it comes time for disposal.
The same structure that helps preserve the medicine complicates the reuse of the empty blister pack, as aluminum and technical plastics are combined in layers that require specific guidance before any recyclable destination.
By creating its own route for some of these packages, the company seeks to remove from regular trash a material that still holds industrial value, especially when disposal follows appropriate instructions and respects applicable sanitary rules.
Components considered valuable by the pharmaceutical company itself, such as aluminum and plastics used in the composition of blisters, can be recovered within the program, preventing empty blister packs from being treated solely as household waste.
Medication blister requires treatment before recycling
Unlike conventional selective collection campaigns, the reuse of these packs depends on the treatment given to the primary packaging, because the blister is in direct contact with the medication and requires additional care before recycling.
To address this step, the methodology approved by Anvisa allows the consumer to perform decontamination in a domestic environment for the products covered by the program, following the instructions provided on the packaging itself.
After this procedure, the pack is no longer treated as waste without a clear destination and can enter a reuse chain, reducing the improper disposal of materials that have already passed through the pharmaceutical industry.
Instead of ending up in common trash without separation, the blister is seen as a source of raw material, provided it is part of the authorized products and receives the treatment indicated by the manufacturer.
Pharmaceutical packaging and circular economy
In addition to blisters, the +Verde program also involves changes in the external packaging of participating medications, expanding the scope of the proposal beyond the empty pack taken from the drawer or home cabinet.
According to Eurofarma, the cartons of these products use paper with 30% recycled content and provide information on correct disposal, connecting packaging, consumer guidance, and post-consumption in a single environmental strategy.
This combination of disposal instructions, changes in external material, and reuse of blisters gives the project a broader character than an isolated recycling action within the pharmaceutical sector.
Questions about the disposal of medications and packaging remain common among consumers, because bottles, boxes, leaflets, and packs are often thrown away together, although they have different compositions and treatment requirements.
In the case of blisters, the challenge becomes greater because the packaging seems small and simple, but it combines layers of different materials, in addition to having direct contact with products subject to sanitary regulations.
Correct disposal of empty medication packs
The presence of this waste at home helps explain the potential impact of the proposal, as practically anyone who uses tablet medications has come into contact with an empty pack at some point.
Despite this familiarity, few consumers associate the blister with aluminum, technical plastic, sanitary regulation, and reuse logistics, elements that transform a common packaging into part of a more complex industrial chain.
For this reason, applying the methodology does not mean that all medication blister packs can be directly placed in recycling collection, without first checking if the product provides specific guidance from the manufacturer.
The initiative refers to products that are part of the program indicated by the company and have their own disposal instructions, an important distinction because pharmaceutical packaging may require different treatments depending on the type of medication.
Even so, this proposal opens a less visible front within the circular economy, an area usually associated with bottles, cans, cardboard, glass, and food packaging, but which also reaches smaller and less remembered waste.
Scattered across homes, pharmacies, and healthcare services, medicine blister packs remain in a lesser-known zone by the public, although they are part of a constant flow of packaging used in daily life.
Domestic waste can return to the production chain
The case shows how environmental innovation can also arise in small objects, especially when a common-looking waste begins to receive technical treatment, disposal guidance, and the possibility of industrial reuse.
An empty blister pack weighs little, takes up little space, and generally disappears in the trash without drawing attention, but represents, when observed on a scale, a continuous flow of aluminum and plastic that needs proper disposal.
By bringing the consumer closer to a stage that is usually restricted to the industry, the Brazilian proposal tries to transform the end of medication use into an organized part of the environmental responsibility chain.
Instructions on the packaging and domestic decontamination in authorized cases change the consumer’s role in this process, because disposal ceases to be an automatic gesture and depends on correct information.
Within the logic of the circular economy, the value of the project lies in the attempt to keep materials in use for longer, reducing the loss of components that can still be utilized after consumption.
The aluminum and plastics present in the blisters do not cease to exist after the last pill is removed, and a safe reuse route allows these materials to return as raw material in other production processes.
A change in perception about domestic waste also gains strength, because not everything that seems small is irrelevant and not all material discarded at home has simple treatment or an obvious destination.
The medication blister pack brings together health, consumption, industry, sanitary regulation, and recycling in a single object, making the journey of packaging that almost always goes unnoticed after use more surprising.
Precisely by uniting the mundane with the unexpected, an empty blister pack that once represented only the end of packaging has come to occupy space in an environmental strategy with technology, regulatory approval, and material reuse.
If an empty medicine blister pack can return to the recycling chain after receiving proper treatment, how many other forgotten wastes inside the house can still have a completely different destination?
